Your complete clinical trial supply solution, from service to expertise

Myonex Clinical Trial Patient Solutions

Yourpartnerforaprescriptionservicewithnosupplyforecastingandnodrugwaste.

 Watch the video below to learn more about Myonex’s latest innovation.

Clinical Trial Prescription Service

Case Studies

Myonex’s Clinical Trial Prescription Service provides access to our specialty pharmacy network and can help reduce overages. See two case study examples below of how our Clinical Trial Prescription Service helped our clients.

With Myonex as your clinical trial supply partner, you’ll gain…

• expert problem-solving and tailored solutions for any challenge

• speedy access to the right supply of drugs so the trial can start on time

• tools for reducing overage to eliminate waste

• flexibility to change drug supply requests

• ways to reduce costs

• answers to your inquiries

Experience the simplicity of working with a single vendor who can handle:

• comparator drug sourcing and supply

• packaging and distribution

• returning or redistributing unused drugs

• providing all equipment and supplies needed for the trial, from IVs and tubing to refrigeration — and everything in between.

Let’s discuss how we can help you plan your next global clinical trial.

Go to article: Home | Waive goodbye to vaccine patentsGo to article: In this issueGo to article: ContentsGo to article: Mimotopes Company Insight Go to article: MimotopesGo to article: DatwylerGo to article: Datwyler Company InsightGo to article: LabcorpGo to article: Biesterfeld Go to article: BriefingGo to article: Industry newsGo to article: The pharma industry briefingGo to article: Covid-19 executive briefing by GlobalDataGo to article: Dr. Paul LohmannGo to article: ButterworthGo to article: SkyepharmaGo to article: BaxterGo to article: CommentGo to article: Speeding up patient access to innovative drugsGo to article: The competitive landscape of neoantigen-targeting therapeutics in oncologyGo to article: Bacterial “cell factories”: an eco-friendly approach to chemical productionGo to article: MDR set to transform how MedTech firms approach content managementGo to article: PerkinElmerGo to article: NiproGo to article: NiproGo to article: In DepthGo to article: Should UK children be vaccinated against chickenpox?Go to article: Fighting India’s ‘black fungus’ epidemicGo to article: What could a vaccine patent waiver mean for pharma manufacturing? Go to article: Algae proteins: a vision of the futureGo to article: A brief history of ALS awareness and its sparse treatments Go to article: Ferring draws closer to a microbiome breakthroughGo to article: The Solubility companyGo to article: Myonex Go to article: Owen MumfordGo to article: In DataGo to article: Data: pharma subsidiaries Go to article: Deals analysisGo to article: The pharma industry key listGo to article: Global markets and indicesGo to article:  Macro-economic indicatorsGo to article: Macro-economic indicators (page 2)Go to article: EventsGo to article: Next issue